Allucent is attending the Rare Trials Summit in Boston!
Connect with Allucent at the Rare Trials Summit in Boston, a specialized, interactive meeting where leaders, researchers, and advocates in rare diseases will explore the latest advancements, challenges, and opportunities in clinical trials. As a rare disease CRO with over 30 years of expertise, we are committed to advancing treatments for complex, hard-to-treat, and orphan conditions through innovative, patient-centric trial designs that address the unique regulatory and operational demands of rare and orphan disease research across multiple therapeutic areas.
Join our session and schedule a meeting to learn more about our rare and orphan disease expertise and how we can support your next clinical trial.
Fill out the form to schedule a meeting.
Featured Session
September 15, 10:45 – 12:00
Workshop: Mapping the Rare Patient Journey
Co-moderator
Maria-Cruz Morillo, Global Head of Advanced Therapies, Rare Disease & CGT, Allucent
As Head of Allucent’s Rare Disease Center of Expertise integrating cross functional expertise to provide strategic solutions for rare disease trials, Maria-Cruz Morillo, MS, has deep knowledge in drug development after 27 years of experience in Project Management and Strategy and IMP Supply in both biotech and CROs. Her strategic mindset and demonstrated ability to design and implement effective study protocols has significantly contributed to the achievement of market authorizations for numerous rare endocrinology and hematology autoimmune programs.
Share This
